United States · FDA National Drug Code directory
CELECOXIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-143_350160e1-34ab-f7e3-e063-6394a90a4508
- Product NDC
- 42571-143
- Form
- CAPSULE
- Composition / generic term
- Celecoxib
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180601
- Source listing expiry
- 20261231
Source-listed ingredients
- CELECOXIB — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (42571-143-01) · 42571-143-01
- 500 CAPSULE in 1 BOTTLE (42571-143-05) · 42571-143-05
- 30 CAPSULE in 1 BOTTLE (42571-143-30) · 42571-143-30
- 7 BLISTER PACK in 1 CARTON (42571-143-33) / 10 CAPSULE in 1 BLISTER PACK (42571-143-32) · 42571-143-33
- 60 CAPSULE in 1 BOTTLE (42571-143-60) · 42571-143-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →